Product Name:1-(4-bromo-2,6-difluoro-phenyl)-3-(2-trimethylsilylethoxymethyl)hexahydropyrimidine-2,4-dione

IUPAC Name:1-(4-bromo-2,6-difluorophenyl)-3-{[2-(trimethylsilyl)ethoxy]methyl}-1,3-diazinane-2,4-dione

CAS:2940940-46-3
Molecular Formula:C16H21BrF2N2O3Si
Purity:95%
Catalog Number:CM1076165
Molecular Weight:435.34

Packing Unit Available Stock Price($) Quantity
CM1076165-100mg in stock ƞƞź
CM1076165-250mg in stock ǯǯǯ
CM1076165-500mg in stock ǕǯŢ
CM1076165-1g in stock ƄƄƄŢ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:2940940-46-3
Molecular Formula:C16H21BrF2N2O3Si
Melting Point:-
Smiles Code:C[Si](C)(C)CCOCN1C(=O)CCN(C1=O)C1=C(F)C=C(Br)C=C1F
Density:
Catalog Number:CM1076165
Molecular Weight:435.34
Boiling Point:
MDL No:
Storage:

Category Infos

PROTAC-E3 Ligase Ligands
Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.